Regulation of let-7 and its target oncogenes (Review).
暂无分享,去创建一个
Ning Liu | Lei Cao | Xi-rui Wang | Yingyi Wang | XieFeng Wang | Ning Liu | Y. You | Yongping You | Xiefeng Wang | Lei Cao | Yingyi Wang | Xirui Wang | Xiefeng Wang
[1] P. Robinson,et al. Ubiquitin-protein ligases , 2004, Journal of Cell Science.
[2] B. Christensen,et al. KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer. , 2010, Lung cancer.
[3] Hui-min Peng,et al. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice , 2010, Journal of Cancer Research and Clinical Oncology.
[4] Peter A. Jones,et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.
[5] L. Smirnova,et al. The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2 , 2009, Nature Cell Biology.
[6] D. Katsaros,et al. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. , 2007, Cancer research.
[7] Manfred Kunz,et al. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth , 2008, Cell Research.
[8] Y. Akao,et al. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.
[9] C. Burge,et al. Identification of let-7-regulated oncofetal genes. , 2008, Cancer research.
[10] F. Slack,et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.
[11] S. Yonehara,et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.
[12] H. Sültmann,et al. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. , 2007, Cancer research.
[13] Patricia Soteropoulos,et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. , 2007, Cancer research.
[14] B. Reinhart,et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.
[15] J. Richter,et al. Human let-7a miRNA blocks protein production on actively translating polyribosomes , 2006, Nature Structural &Molecular Biology.
[16] Richard J Lamont,et al. Overexpression of dicer as a result of reduced let‐7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells , 2010, Genes, chromosomes & cancer.
[17] C. Joo,et al. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. , 2008, Molecular cell.
[18] Xianjun Wang,et al. Detection of let-7a microRNA by real-time PCR in gastric carcinoma. , 2007, World journal of gastroenterology.
[19] Shan Wang,et al. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. , 2004, World journal of gastroenterology.
[20] M. Narita,et al. Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma , 2008, Journal of cellular and molecular medicine.
[21] M. Henriksson,et al. MYC in oncogenesis and as a target for cancer therapies. , 2010, Advances in cancer research.
[22] Keun-Hwa Jung,et al. Let-7 microRNA inhibits the proliferation of human glioblastoma cells , 2011, Journal of Neuro-Oncology.
[23] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[24] Mark Gerstein,et al. The temporal patterning microRNA let-7 regulates several transcription factors at the larval to adult transition in C. elegans. , 2005, Developmental cell.
[25] S. Knuutila,et al. Increased expression of high mobility group A proteins in lung cancer , 2006, The Journal of pathology.
[26] Junxia Chen,et al. Let‐7a elevates p21WAF1 levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells , 2009, FEBS letters.
[27] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[28] J. Bullerdiek,et al. Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias , 2008, Genes, chromosomes & cancer.
[29] R. Gregory,et al. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in embryonic stem cells , 2009, Nature Structural &Molecular Biology.
[30] Yuanjia Tang,et al. Let-7/miR-98 regulate Fas and Fas-mediated apoptosis , 2011, Genes and Immunity.
[31] M. Peter,et al. The CD95 Receptor: Apoptosis Revisited , 2007, Cell.
[32] A. Fusco,et al. Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer , 2004, FEBS letters.
[33] Joshua J. Forman,et al. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence , 2008, Proceedings of the National Academy of Sciences.
[34] M. Esteller. Relevance of DNA methylation in the management of cancer. , 2003, The Lancet. Oncology.
[35] V. Kim,et al. Biogenesis of small RNAs in animals , 2009, Nature Reviews Molecular Cell Biology.
[36] N. Seki,et al. Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines. , 2011, Oncology reports.
[37] Thomas Weigel,et al. HMGA2 overexpression in non‐small cell lung cancer , 2007, Molecular carcinogenesis.
[38] L. Borrmann,et al. The expression of HMGA genes is regulated by their 3′UTR , 2001, Oncogene.
[39] Tsung-Cheng Chang,et al. Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.
[40] V. Ambros,et al. A feedback circuit involving let-7-family miRNAs and DAF-12 integrates environmental signals and developmental timing in Caenorhabditis elegans , 2009, Proceedings of the National Academy of Sciences.
[41] P. Cagle,et al. Expression of activated and latent signal transducer and activator of transcription 3 in 303 non-small cell lung carcinomas and 44 malignant mesotheliomas: possible role for chemotherapeutic intervention. , 2007, Archives of pathology & laboratory medicine.
[42] H. Saya,et al. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? , 2007, Pharmacology & therapeutics.
[43] Y. Atomi,et al. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue , 2003, British Journal of Cancer.
[44] E. Kleinerman,et al. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[45] Dong Liang,et al. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. , 2010, Cancer research.
[46] F. Slack,et al. The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.
[47] S. Dangi‐Garimella,et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7 , 2009, The EMBO journal.
[48] R. Vierkant,et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. , 2011, Cancer research.
[49] Kenichi Sugihara,et al. Clinical Significance of High Mobility Group A2 in Human Gastric Cancer and Its Relationship to let-7 MicroRNA Family , 2008, Clinical Cancer Research.
[50] J. M. Thomson,et al. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. , 2008, RNA.
[51] A. Pasquinelli,et al. A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.
[52] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[53] J. Grandis,et al. STAT3 as a therapeutic target in head and neck cancer , 2006, Expert opinion on biological therapy.
[54] W. Sung,et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. , 2010, Journal of hepatology.
[55] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[56] M. Fraga,et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. , 2007, Cancer research.
[57] V. Ambros,et al. Drosophila let-7 microRNA is required for remodeling of the neuromusculature during metamorphosis. , 2008, Genes & development.
[58] D. Ruggero. The role of Myc-induced protein synthesis in cancer. , 2009, Cancer research.
[59] Tsung-Cheng Chang,et al. microRNAs in vertebrate physiology and human disease. , 2007, Annual review of genomics and human genetics.
[60] G. Daley,et al. Selective Blockade of MicroRNA Processing by Lin28 , 2008, Science.
[61] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[62] David P. Bartel,et al. Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .
[63] C. Joo,et al. TUT4 in Concert with Lin28 Suppresses MicroRNA Biogenesis through Pre-MicroRNA Uridylation , 2009, Cell.
[64] Roy Garcia,et al. STATs in oncogenesis , 2000, Oncogene.
[65] David I. K. Martin,et al. microRNA-Mediated Messenger RNA Deadenylation Contributes to Translational Repression in Mammalian Cells , 2009, PloS one.
[66] Piotr Sliz,et al. Determinants of MicroRNA Processing Inhibition by the Developmentally Regulated RNA-binding Protein Lin28* , 2008, Journal of Biological Chemistry.
[67] Jiamei Yang,et al. A let-7/Fas double-negative feedback loop regulates human colon carcinoma cells sensitivity to Fas-related apoptosis. , 2011, Biochemical and biophysical research communications.
[68] C. Perou,et al. A custom microarray platform for analysis of microRNA gene expression , 2004, Nature Methods.
[69] L. Fan,et al. Germline Genetic Variants Disturbing the Let-7/LIN28 Double-Negative Feedback Loop Alter Breast Cancer Susceptibility , 2011, PLoS genetics.
[70] M. Peter,et al. CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells , 2004, The EMBO journal.
[71] T. Nilsen,et al. Mechanisms of microRNA‐mediated gene regulation , 2007, Trends in genetics : TIG.
[72] A. Antsaklis,et al. CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells* , 2005, Journal of Biological Chemistry.
[73] S. Balasubramanian,et al. LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans , 2009, Nature Structural &Molecular Biology.
[74] D. Haber,et al. Dual Role for Argonautes in MicroRNA Processing and Posttranscriptional Regulation of MicroRNA Expression , 2007, Cell.
[75] Kevin Struhl,et al. An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.
[76] H. Saya,et al. Down‐regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1‐dependent DNA‐damage checkpoint signals contributes to cell cycle arrest at G1/S transition , 2004, Genes to cells : devoted to molecular & cellular mechanisms.
[77] E. Hatano,et al. The NF90-NF45 Complex Functions as a Negative Regulator in the MicroRNA Processing Pathway , 2009, Molecular and Cellular Biology.
[78] F. Slack,et al. The let-7 family of microRNAs. , 2008, Trends in cell biology.
[79] L. Johnston,et al. Temporal Regulation of Metamorphic Processes in Drosophila by the let-7 and miR-125 Heterochronic MicroRNAs , 2008, Current Biology.
[80] David Tuck,et al. A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. , 2011, The Lancet. Oncology.
[81] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[82] M. Ehrlich,et al. DNA methylation in cancer: too much, but also too little , 2002, Oncogene.
[83] G. Petsko. Transformation , 2006, Genome Biology.
[84] Michael A. Beer,et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation , 2009, Proceedings of the National Academy of Sciences.
[85] K. Chada,et al. Expression of Mesenchyme-Specific Gene HMGA2 in Squamous Cell Carcinomas of the Oral Cavity , 2004, Cancer Research.
[86] J. Steitz,et al. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR , 2007, Proceedings of the National Academy of Sciences.